Joel Greenblatt's ADMA Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 13,627 shares of ADMA Biologics, Inc. (ADMA) worth $248,556, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in ADMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 86,417 shares. Largest reduction occurred in Q3 2025, reducing 97,982 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2,616 | Add 23.76% | 13,627 | $18.24 |
| Q3 2025 | -97,982 | Reduce 89.90% | 11,011 | $14.66 |
| Q2 2025 | -55,254 | Reduce 33.64% | 108,993 | $18.21 |
| Q1 2025 | -2,447 | Reduce 1.47% | 164,247 | $19.84 |
| Q4 2024 | +2,129 | Add 1.29% | 166,694 | $17.15 |
| Q3 2024 | +86,417 | Add 110.58% | 164,565 | $19.99 |
| Q2 2024 | -17,332 | Reduce 18.15% | 78,148 | $11.18 |
| Q1 2024 | +25,891 | Add 37.21% | 95,480 | $6.60 |
| Q4 2023 | -6,030 | Reduce 7.97% | 69,589 | $4.52 |
| Q3 2023 | +14,564 | Add 23.85% | 75,619 | $3.58 |
| Q2 2023 | +29,532 | Add 93.68% | 61,055 | $3.69 |
| Q1 2023 | -10,987 | Reduce 25.85% | 31,523 | $3.31 |
| Q4 2022 | +42,510 | New Buy | 42,510 | $3.88 |
Joel Greenblatt's ADMA Biologics Investment FAQs
Joel Greenblatt first purchased ADMA Biologics, Inc. (ADMA) in Q4 2022, acquiring 42,510 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held ADMA Biologics, Inc. (ADMA) for 13 quarters since Q4 2022.
Joel Greenblatt's largest addition to ADMA Biologics, Inc. (ADMA) was in Q3 2024, adding 164,565 shares worth $3.29 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 13,627 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $248,556.
As of the Q4 2025 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in ADMA Biologics, Inc. (ADMA) was 166,694 shares, as reported at the end of Q4 2024.